PULMOTIL AC DIN 02393638
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Molecule: TILMICOSIN (TILMICOSIN PHOSPHATE)
Health Canada record
| Active ingredient(s) | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 06-May-2013 |
| Current status date | 31-Dec-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TILMICOSIN (TILMICOSIN PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240124 | PULMOTIL PREMIX | ELANCO CANADA LIMITED | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02513811 | RESPOTIL | MODERN VETERINARY THERAPEUTICS LLC | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Marketed |
| 02461099 | TILMICOSIN 200 | BIO AGRI MIX LP | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02482150 | TILMICOSIN AC | BIO AGRI MIX LP | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Approved |
| 02349507 | TILMOVET PREMIX | HUVEPHARMA EOOD | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20142 | 2017-12-08 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 18127 | 2016-05-24 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION; UPDATE TO CURRENT INDICATION |
| 13680 | 2012-09-28 | New Drug Submission (NDS) |